Varga B, Paksy K, Náray M
Department of Experimental Toxicology, National Institute of Occupational Health, Budapest, Hungary.
Acta Physiol Hung. 1991;78(3):221-6.
Wistar rats were given 0.25, 0.5 or 1.0 mg/kg/week CdCl2 for 14, 18 or 22 weeks and the body weight, Cd content of ovaries, adrenals, pituitary gland, furthermore the progesterone and oestradiol-17 beta secretion of ovary were checked. Cd treatment caused a slight decrease in the body weight, but failed to alter the weight of endocrine organs. CdCl2 in a dose of 0.25 mg/kg/week resulted in almost the same Cd content in all the three organs. Rising the amount of Cd administered the pituitary gland accumulated more Cd than the adrenals, and the lowest levels were found in the ovary. CdCl2 even in the dose of 1.0 mg/kg/week failed to alter the ovarian cycle, progesterone and oestradiol-17 beta production of ovary. The data point also to a developing tolerance to Cd as the cumulative dose of CdCl2 lies close to the LD50 levels.
给Wistar大鼠每周注射0.25、0.5或1.0mg/kg的CdCl₂,持续14、18或22周,然后检测其体重、卵巢、肾上腺、垂体中的镉含量,以及卵巢中孕酮和雌二醇-17β的分泌情况。镉处理导致体重略有下降,但未能改变内分泌器官的重量。每周0.25mg/kg剂量的CdCl₂使所有三个器官中的镉含量几乎相同。随着镉给药量的增加,垂体积累的镉比肾上腺更多,而卵巢中的镉含量最低。即使是每周1.0mg/kg剂量的CdCl₂也未能改变卵巢周期、卵巢中孕酮和雌二醇-17β的产生。数据还表明,随着CdCl₂的累积剂量接近半数致死量水平,对镉的耐受性正在形成。